Latest Funding News

The Australian Wealth Advisors Group Ltd (AWAG) reported a 13% revenue increase and a $1.2 million profit before tax in FY2025, driven by strategic Equity Partnership Scheme investments and a strong funds under management base.

The Australian Wealth Advisors Group Ltd (AWAG) reported a $1.18 million net profit before tax in its first full year as an ASX-listed company, reversing a prior loss and growing revenue by 13%. The company expanded its funds under management and equity investments, positioning itself for further industry consolidation.

Dome Gold Mines has updated the schedule for its Share Purchase Plan, setting new dates for offer opening, closing, and share issuance through September 2025. This move aligns with ongoing development efforts at its Fiji-based mining projects.

Ark Mines has landed a $4.5 million investment from Queensland’s Critical Minerals and Battery Technology Fund, accelerating development at its Sandy Mitchell rare earths project with production targeted for late 2027.

Vital Metals Limited has had its trading suspension lifted following announcements addressing an ASX Price and Volume Query and a new capital raise, signaling renewed market activity.

Vital Metals has raised A$6.8 million through a strategic placement led by US-based Strategic Resources LLC to advance its Tardiff Rare Earth project in Canada, aiming to deploy innovative Dry Field Force Extraction technology that could reshape project economics and environmental impact.

Australian Unity Office Fund’s planned $63.5 million sale of 150 Charlotte Street, Brisbane, has hit a snag with the purchaser defaulting on settlement, prompting a sharp valuation downgrade and withdrawal of distribution guidance.

Locksley Resources has partnered with Rice University to pioneer domestic antimony processing in the US, aiming to reduce reliance on foreign supply and support critical defense and energy sectors.

WAM Microcap Limited has outperformed the ASX Small Ordinaries Index for the eighth consecutive year, posting an 18.8% portfolio gain and raising its fully franked dividend to 10.6 cents per share.

360 Capital Group (ASX – TGP) reported a 15% rise in operating profit for FY25 and announced a substantial $78.8 million special distribution, reflecting strong momentum in its real estate and credit platforms.

InhaleRx Limited reported a widening half-year loss as it accelerates clinical trials for inhaled drug-device therapies, supported by a substantial $38.5 million funding facility.

360 Capital Group has reported a significant profit increase for FY25 alongside a stable dividend and a substantial $0.40 per security special distribution, reflecting strong cash reserves and strategic growth in real estate credit.